{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T10:20:20Z","timestamp":1785320420618,"version":"3.55.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2017,4,7]],"date-time":"2017-04-07T00:00:00Z","timestamp":1491523200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1007\/s10072-017-2936-3","type":"journal-article","created":{"date-parts":[[2017,4,7]],"date-time":"2017-04-07T07:23:36Z","timestamp":1491549816000},"page":"1187-1191","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Combined visual and semi-quantitative assessment of 123I-FP-CIT SPECT for the diagnosis of dopaminergic neurodegenerative diseases"],"prefix":"10.1007","volume":"38","author":[{"given":"Jun","family":"Ueda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hajime","family":"Yoshimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiji","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megumu","family":"Hino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuo","family":"Kohara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,4,7]]},"reference":[{"key":"2936_CR1","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1002\/mds.20112","volume":"19","author":"AM Catafau","year":"2004","unstructured":"Catafau AM, Tolosa E (2004) Impact of dopamine transporter SPECT using 123I-ioflupane on diagnosis and management of patients with clinically uncertain parkinsonian syndromes. Mov Disord 19:1175\u20131182","journal-title":"Mov Disord"},{"key":"2936_CR2","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1136\/jnnp-2012-304436","volume":"84","author":"N Bajaj","year":"2013","unstructured":"Bajaj N, Hauser RA, Grachev ID (2013) Clinical utility of dopamine transporter single photon emission CT (DaT-SPECT) with (123I) ioflupane in diagnosis of parkinsonian syndromes. J Neurol Neurosurg Psychiatry 84:1288\u20131295","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2936_CR3","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1002\/1531-8257(200005)15:3<503::AID-MDS1013>3.0.CO;2-V","volume":"15","author":"HTS Benamer","year":"2000","unstructured":"Benamer HTS, Patterson J, Grosset DG (2000) Accurate differentiation of parkinsonism and essential tremor using visual assessment of [123I]FP-CIT SPET imaging: the[123I]FP-CIT SPET study group. Mov Disord 15:503\u2013510","journal-title":"Mov Disord"},{"key":"2936_CR4","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1136\/jnnp.55.3.181","volume":"55","author":"AJ Hughes","year":"1992","unstructured":"Hughes AJ, Daniel SE, Kilford L et al (1992) Accuracy of clinical diagnosis of idiopathic Parkinson\u2019s disease. A clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 55:181\u2013184","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2936_CR5","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1212\/01.wnl.0000187889.17253.b1","volume":"65","author":"IG McKeith","year":"2005","unstructured":"McKeith IG, Dickson DW, Lowe J et al (2005) Diagnosis and management of dementia with Lewy bodies: third report of the DLB consortium. Neurology 65:1863\u20131872","journal-title":"Neurology"},{"key":"2936_CR6","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1212\/01.wnl.0000324625.00404.15","volume":"71","author":"S Gilman","year":"2008","unstructured":"Gilman S, Wenning GK, Low PA et al (2008) Second consensus statement on the diagnosis of multiple system atrophy. Neurology 71:670\u2013676","journal-title":"Neurology"},{"key":"2936_CR7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1212\/WNL.47.1.1","volume":"47","author":"I Litvan","year":"1996","unstructured":"Litvan I, Agid Y, Calne D et al (1996) NINDS-Society for PSP, Inc. (SPSP) diagnostic criteria. Neurology 47:1\u20139","journal-title":"Neurology"},{"key":"2936_CR8","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1212\/WNL.0b013e31827f0fd1","volume":"80","author":"MJ Armstrong","year":"2013","unstructured":"Armstrong MJ, Litvan I, Lang AE et al (2013) Criteria for the diagnosis of corticobasal degeneration. Neurology 80:496\u2013503","journal-title":"Neurology"},{"key":"2936_CR9","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1007\/s00259-006-0155-x","volume":"33","author":"L Tossici-Bolt","year":"2006","unstructured":"Tossici-Bolt L, Hoffmann SM, Kemp PM et al (2006) Quantification of [123I]FP-CIT SPECT brain images: an accurate technique for measurement of the specific binding ratio. Eur J Nucl Med Mol Imaging 33:1491\u20131499","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2936_CR10","unstructured":"FDA prescribing information for DaTscan website. \nhttp:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/nda\/2011\/022454sOrig1s000Lbl.pdf\n\n. Accessed 9 Jan 2017"},{"key":"2936_CR11","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/2191-219X-2-45","volume":"2","author":"A Seret","year":"2012","unstructured":"Seret A, Nguyen D, Bernard C (2012) Quantitative capabilities of four state-of-the-art SPECT-CT cameras. EJNMMI Res 2:45","journal-title":"EJNMMI Res"},{"key":"2936_CR12","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1590\/S0004-282X2012000900004","volume":"70","author":"MA Utiumi","year":"2012","unstructured":"Utiumi MA, Felicio AC, Borges CR et al (2012) Dopamine transporter imaging in clinically unclear cases of parkinsonism and the importance of scans without evidence of dopaminergic deficit (SWEDDs). Arq Neuropsiquiatr 70:667\u2013673","journal-title":"Arq Neuropsiquiatr"},{"key":"2936_CR13","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1093\/brain\/122.8.1449","volume":"122","author":"MA Piggott","year":"1999","unstructured":"Piggott MA, Marshall EF, Thomas N et al (1999) Striatal dopaminergic markers in dementia with Lewy bodies, Alzheimer\u2019s and Parkinson\u2019s diseases: rostrocaudal distribution. Brain 122:1449\u20131468","journal-title":"Brain"},{"key":"2936_CR14","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1002\/1531-8257(200007)15:4<692::AID-MDS1014>3.0.CO;2-V","volume":"15","author":"HTS Benamer","year":"2000","unstructured":"Benamer HTS, Patterson J, Wyper D et al (2000) Correlation of Parkinson\u2019s disease severity and duration with [123I]FP-CIT SPECT striatal uptake. Mov Disord 15:692\u2013698","journal-title":"Mov Disord"},{"key":"2936_CR15","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1002\/mds.10579","volume":"18","author":"W Pirker","year":"2003","unstructured":"Pirker W (2003) Correlation of dopamine transporter imaging with parkinsonian motor handicap: how close is it? Mov Disord 18:43\u201351","journal-title":"Mov Disord"},{"key":"2936_CR16","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1007\/s12149-014-0878-x","volume":"28","author":"A Davidsson","year":"2014","unstructured":"Davidsson A, Georgiopoulos C, Dizdar N et al (2014) Comparison between visual assessment of dopaminergic degeneration pattern and semi-quantitative ratio calculations in patients with Parkinson\u2019s disease and atypical parkinsonian syndromes using DaTSCAN\u00ae SPECT. Ann Nucl Med 28:851\u2013859","journal-title":"Ann Nucl Med"},{"key":"2936_CR17","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s10072-006-0718-4","volume":"27","author":"S Ottaviani","year":"2006","unstructured":"Ottaviani S, Tinazzi M, Pasquin I et al (2006) Comparative analysis of visual and semi-quantitative assessment of striatal [123I]FP-CITSPET binding in Parkinson\u2019s disease. Neurol Sci 27:397\u2013401","journal-title":"Neurol Sci"},{"key":"2936_CR18","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1007\/s12149-011-0564-1","volume":"26","author":"N Papathanasiou","year":"2012","unstructured":"Papathanasiou N, Rondogianni P, Chroni P et al (2012) Interobserver variability, and visual and quantitative parameters of (123)I-FP-CIT SPECT (DaTSCAN) studies. Ann Nucl Med 26:234\u2013240","journal-title":"Ann Nucl Med"},{"key":"2936_CR19","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s00259-009-1212-z","volume":"37","author":"JC Dickson","year":"2010","unstructured":"Dickson JC, Tossici-Bolt L, Sera T et al (2010) The impact of reconstruction method on the quantification of DaTSCAN images. Eur J Nucl Med Mol Imaging 37:23\u201335","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2936_CR20","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1097\/MNM.0b013e328314b863","volume":"30","author":"RT Staff","year":"2009","unstructured":"Staff RT, Ahearn TS, Wilson K et al (2009) Shape analysis of 123I-N-omega-fluoropropyl-2-beta-carbomethoxy-3beta-(4-iodophenyl) nortropane single-photon emission computed tomography images in the assessment of patients with parkinsonian syndromes. Nucl Med Commun 30:194\u2013201","journal-title":"Nucl Med Commun"},{"key":"2936_CR21","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1007\/s00259-010-1664-1","volume":"38","author":"K Badiavas","year":"2011","unstructured":"Badiavas K, Molyvda E, Iakovou I et al (2011) SPECT imaging evaluation in movement disorders: far beyond visual assessment. Eur J Nucl Med Mol Imaging 38:764\u2013773","journal-title":"Eur J Nucl Med Mol Imaging"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10072-017-2936-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-017-2936-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-017-2936-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,28]],"date-time":"2017-06-28T08:47:24Z","timestamp":1498639644000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10072-017-2936-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4,7]]},"references-count":21,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2017,7]]}},"alternative-id":["2936"],"URL":"https:\/\/doi.org\/10.1007\/s10072-017-2936-3","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"value":"1590-1874","type":"print"},{"value":"1590-3478","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,4,7]]}}}